🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This trial is testing two novel combinations (temozolomide plus osimertinib...
Status
Completed
Location
University of Colorado Hospital
Start Date
2020-10-29
Trial ID
NCT04541407
Treatments Being Tested
The goal of this study is to determine the response of the study drug lorat...
Status
Recruiting
Location
Children's Hospital Colorado
Start Date
2025-08-03
Trial ID
NCT06333899
Phase 1/2, dose escalation and expansion study designed to evaluate the saf...
Status
Recruiting
Location
University of California Irvine Medical Center
Start Date
2022-06-09
Trial ID
NCT05384626
Treatments Being Tested
Lorlatinib is a novel inhibitor across ALK variants, including those resist...
Status
Completed
Location
Children's Hospital Los Angeles
Start Date
2017-09-05
Trial ID
NCT03107988
Treatments Being Tested
The purpose of this study is to assess the Treatment Strategies and Surviva...
Status
Recruiting
Location
Yongchang Zhang
Start Date
2020-04-16
Trial ID
NCT04322890
Treatments Being Tested
Although many phase III clinical trials evaluate the quality of life as a s...
Status
Recruiting
Location
Fondazione Policlinico Gemelli IRCCS
Start Date
2024-08-05
Trial ID
NCT06532149
This phase III trial studies iobenguane I-131 or lorlatinib and standard th...
Status
Recruiting
Location
Children's Hospital of Alabama
Start Date
2018-05-14
Trial ID
NCT03126916
Treatments Being Tested
The project is a Phase III, randomized, open-label, multicenter study in wh...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-03
Trial ID
NCT06858410
Treatments Being Tested
The primary purpose of this study is to determine the differences in PFS fo...
Status
Completed
Location
EmpiraMed, Inc.
Start Date
2018-07-23
Trial ID
NCT03546894
Treatments Being Tested
This study aims to evaluate the activity and safety of the combination of p...
Status
Recruiting
Location
Centro di Riferimento Oncologico (CRO) IRCCS
Start Date
2024-03-15
Trial ID
NCT06378892
Treatments Being Tested